Lennox-Gastaut Syndrome (LGS) accounts for only 2 to 5% of childhood epilepsies, yet children with this epilepsy syndrome often are well known to their pediatric neurologist. This disparity is due to the tendency for seizures to be hard to control, the requirement for long-term treatment (often with medical and non-medical therapies), and the intellectual impairment, all of which cause children with LGS to make frequent visits to their physicians. Unfortunately, this epilepsy syndrome usually persists through childhood and adolescence to adult years (changing some in its presentation with age) requiring familiarity by all health care professionals. In the last few years, several new treatments have emerged. While none are a cure for LGS, this is good news for a group of children that historically has had few good treatment options.
Author: James Wheless, M.D.